These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8354633)
1. Myopathy in long-term AZT therapy: clinical, electrophysiological and biopsy study in 67 HIV+ subjects. Spadaro M; Tilia G; Massara MC; Damiani A; Parisi L; Tomelleri G; D'Offizi G; Morocutti C Ital J Neurol Sci; 1993 Jun; 14(5):369-74. PubMed ID: 8354633 [TBL] [Abstract][Full Text] [Related]
2. Prognosis in AZT myopathy. Chalmers AC; Greco CM; Miller RG Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057 [TBL] [Abstract][Full Text] [Related]
3. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Casado E; Gratacós J; Tolosa C; Martínez JM; Ojanguren I; Ariza A; Real J; Sanjuán A; Larrosa M Ann Rheum Dis; 2006 Mar; 65(3):385-90. PubMed ID: 16096334 [TBL] [Abstract][Full Text] [Related]
4. Asymptomatic hyper-CK-emia: an electrophysiologic and histopathologic study. Joy JL; Oh SJ Muscle Nerve; 1989 Mar; 12(3):206-9. PubMed ID: 2725551 [TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle studies in patients with HIV-related wasting syndrome. Miró O; Pedrol E; Cebrián M; Masanés F; Casademont J; Mallolas J; Grau JM J Neurol Sci; 1997 Sep; 150(2):153-9. PubMed ID: 9268244 [TBL] [Abstract][Full Text] [Related]
6. High serum levels of creatine kinase: asymptomatic prelude to distal myopathy. Galassi G; Rowland LP; Hays AP; Hopkins LC; DiMauro S Muscle Nerve; 1987 May; 10(4):346-50. PubMed ID: 3587269 [TBL] [Abstract][Full Text] [Related]
7. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Lane RJ; McLean KA; Moss J; Woodrow DF Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024 [TBL] [Abstract][Full Text] [Related]
8. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine. Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554 [TBL] [Abstract][Full Text] [Related]
11. Labetalol-induced toxic myopathy. Teicher A; Rosenthal T; Kissin E; Sarova I Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1824-5. PubMed ID: 6786636 [TBL] [Abstract][Full Text] [Related]
12. Colchicine-induced myopathy with normal creatine phosphokinase level in a renal transplant patient. Caglar K; Safali M; Yavuz I; Odabaşi Z; Yenicesu M; Vural A Nephron; 2002 Dec; 92(4):922-4. PubMed ID: 12399640 [TBL] [Abstract][Full Text] [Related]
15. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family. Trøseid M; Henriksen OA; Lindal S APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940 [TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus. Richter JG; Becker A; Ostendorf B; Specker C; Stoll G; Neuen-Jacob E; Schneider M Rheumatol Int; 2003 Nov; 23(6):319-23. PubMed ID: 12739036 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Scruggs ER; Dirks Naylor AJ Pharmacology; 2008; 82(2):83-8. PubMed ID: 18504416 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic outcome of muscle biopsy. Shaibani A; Jabari D; Jabbour M; Arif C; Lee M; Rahbar MH Muscle Nerve; 2015 May; 51(5):662-8. PubMed ID: 25187298 [TBL] [Abstract][Full Text] [Related]
19. Zebra body myopathy. Clinical, histochemical and ultrastructural studies. Lake BD; Wilson J J Neurol Sci; 1975 Apr; 24(4):437-46. PubMed ID: 163896 [TBL] [Abstract][Full Text] [Related]
20. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Pezeshkpour G; Illa I; Dalakas MC Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]